# FDA Inspection 1040496 - Octapharma Plasma, Inc - January 10, 2018

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/4620eabb-af3f-404c-9aa0-fae07eebd201
Source feed: FDA_Inspections

> FDA Inspection 1040496 for Octapharma Plasma, Inc on January 10, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040496
- Company Name: Octapharma Plasma, Inc
- Inspection Date: 2018-01-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 956404 - 2016-01-15](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/0342750b-2bfa-4573-bb77-f899c818c196)
- [FDA Inspection 854883 - 2013-11-08](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/12f47296-7c83-41a4-9ccb-0d3cebaec64e)
- [FDA Inspection 763237 - 2011-12-30](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/127c0ec0-25a6-45ed-b911-a2bd425ff1c1)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/f96adc1a-684e-416c-8d21-a8727ab14b08

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d